In this prospective study we aimed to determine whether there is any relationship between enteral feeding, gastric colonisation and diarrhoea in the critically ill patient. Sixty-two critically ill patients from an intensive care unit of a major teaching hospital, who satisfied the usual criteria for enteral feeding, were randomised to receive enteral feeding or not for three days followed by a second randomisation to enterally feed or not for three days. Diarrhoea was recorded and cultures taken of both gastric aspirates and stool.
Enteral feeding via a nasogastric tube is the mainstay of nutritional support in ICU patients with a functioning gastrointestinal tract but unable to take food orally. Enteral feeding has been commonly blamed for the development and continuation of diarrhoea. It is common practice to then cease enteral feeding. The incidence of diarrhoea in acutely ill patients has been reported between 13% and 63070 depending upon the type of feed, previous nutritional history and patient selection. [1] [2] [3] [4] [5] Hypoalbuminaemia, antibiotic usage, osmolality and infusion rate of the enteral feed and contamination of the feeding solution have all been variously implicated as causative. 5 -8 Colonisation of the upper gastrointestinal tract in critically ill patients has been thought to be implicated in the development of nosocomial pneumonias. 9 It is unclear if colonisation of the stomach with pathogenic organisms is related to the development of feeding-associated diarrhoea. We undertook this study to determine the incidence of diarrhoea in enterally fed patients in our ICU and to determine if there was any relationship to gastric colonisation.
Myers Corporation, Evansville, U.S.A.) were entered into the study. Patients were excluded if they had no bowel sounds, and nasogastric aspirates for the previous day exceeded 300 m1l24 hours (Le failed our usual criteria for the commencement of enteral feeding). They were also excluded if Isocal was an unsuitable feed, if they had diarrhoea, or a major bowel resection. Patients were removed from the study if they failed enteral feeding (residual gastric volume [RGV] exceeding 100 ml at the end of two consecutive 4-hour periods), commenced an oral diet, were given an alternative feeding preparation or died. Most patients in the study had not been enterally fed for at least three days prior to entry as they were either in the acute stage of their illness or on parenteral nutrition.
Isocal was prepared according to our usual practice: the feed was prepared in the kitchen by decanting a pre-prepared formula feed (Isocal) into a clean, nonsterile feeding container which was then sealed and despatched to the ICU. In the ward, clean non-sterile tubing connected the feeding container to the nasogastric tube. The enteral feeding circuit was broken to administer medication and to determine gastric residual volume. The residual feed, container and tubing were discarded after 24 hours.
Upon entrance into the study, patients were randomised to one of four groups-to receive Isocal for three days or no enteral feed for three days, followed by enteral feed or no feed for three days. There were four groups identified as feedlfeed (F/F), feed/no feed (F/N), no feedlfeed (N/F), and no feed/no feed (N/N).
Randomisation was performed by shuffling cards and producing batches of 15 protocol sheets to be used in order.
Usual enteral feeding practice was followed. Isocal was given via an enteral feeding tube (8 French Flexiflo, Ross Laboratories, Columbus, Ohio) initially at 40 mllhour and increased by 20 mllhour every 12 hours until the desired caloric load was reached. Caloric requirements were determined using the Schofield equation with a correction for stress. The RGV was determined every four hours by aspiration of the nasogastric tube. Enteral feeding was temporarily ceased if the residual gastric volume exceeded 100 ml and reattempted after four hours. The no enteral feed allocation did not preclude the patient from receiving parenteral nutrition, so that all patients received nitrogen and calories during the study.
Diarrhoea was defined as liquid stools of greater than 200 mll24 hours (to exclude persistent faecal soiling from anal incontinence in the unconscious patient) or more than three soft (i.e. partially formed) stools/day. Stool frequency, formation and "best estimate" stool volume were recorded on the study protocol sheet at the bedside. The bedside nurse was also interviewed by one of the authors if the stool was not available for viewing.
Gastric aspirates were cultured on entrance into the study and on the last of both three-day periods. Gastric aspirates were obtained by aspirating the nasogastric tube. If no sample was obtained, then a 10 ml wash with normal saline via the nasogastric tube was obtained for culture. The sample was sent to the microbiology laboratory in a sterile container. A volume of 25 to 50 JlI of aspirate was placed onto Horse Blood and MacConkey agars and incubated aerobically at 35 QC for two days. Gram negative bacilli, yeasts and Staphylococcus aureus were identified and quantitated according to the number of colonies present in the primary, secondary or tertiary streaks as +, + + , + + + . No colony counts per ml of fluid were performed. Gastric colonisation was defined as a positive culture and the organism(s) recovered were recorded.
Diarrhoeal stools were collected fresh and sent to the laboratory in a sterile container. In the laboratory, faeces were examined macroscopically and liquid areas preferentially selected for culture. Five grams of faeces were emulsified into 5 ml tryptone water. After standing for 10 minutes, 0.5 ml supernatant was inoculated into selenite enrichment medium, xylose-lysinedesoxycholate agar, desoxycholate agar and Ryan's medium, and incubated aerobically at 37 QC for two days. Campylobacter medium and cefoxitincycloserine-fructose-egg yolk agar were also inoculated and incubated at 42 QC in 5070 02, 10070 C02, 85070 N2 and at 37 QC anaerobically for two days. For Cl. difficile toxin detection, faeces were diluted in phosphate buffered saline, centrifuged at 3000g for 15 minutes, filtered through 0.45 Jlm filter and added to MRC-5 monolayers.
Patient demographic data including diagnosis, severity of illness class, 10 therapeutic intervention score (TISS), 11 serum albumin concentrations and antibiotic therapy were recorded.
Fisher's exact test for a 2 x 2 contingency table was used to analyse the results with P < 0.05 taken as significant. A study of 60 patients has a power of 80070 to detect a 25070 difference in the incidence of diarrhoea if the background incidence is 20070. A 25070 difference was taken as that which would be clinically significant.
RESULTS
One hundred patients were entered into the study. Patients who failed to complete the first three days of the study were not analysed further other than to record the cause of failure. Sixty-two patients, 36 males (M) and 26 females (F), completed at least the first threeday period of the study. Forty patients completed all six days of the study. In the FIF group there were 19 patients (14 M, 5 F) whose average age was 55 ± 16 years. In the FIN group, there were seven patients (4 M, 3 F), average age 59 ± 13 years. In the N/F group, there were 19 patients (9 M, 10 F), average age 50± 18, and in N/N 17 patients (9 M, 8 F), average age 54±16 years ( Table 1 ). The distribution of patient diagnosis categories are shown for each group. The four groups were evenly matched for age, class and TISS. The FIF group had relatively more males and the FIN group was numerically smaller.
In FIF, eight patients developed diarrhoea, 4/19 in the first three-day period and 4/11 in the second. None of these patients had diarrhoea in both three-day periods. In FIN, two patients developed diarrhoea. One had diarrhoea in both three-day periods and one only in the second. The incidence of diarrhoea in all patients fed for the first three days was 5126 (19070). In N/N, four patients developed diarrhoea. Three had diarrhoea in the first three days and one in the second. In N/F, six patients had diarrhoea. Four of these had diarrhoea over both three-day periods and two had diarrhoea in the second three-day period alone. The incidence of diarrhoea in all patients not fed for the first three-day randomisation period was 7/36 (19070) . Two patients of 12 (16070) developed diarrhoea whilst fed in the second randomisation period following a no-feed first randomisation period without diarrhoea. One patient of five (20070) developed diarrhoea in the second no-feed randomisation following a feed first randomisation without diarrhoea. Eleven patients received no enteral feed over the six-day period. Four of these patients developed diarrhoea (36070). Eleven patients received six days of enteral feeding, and five (45%) developed diarrhoea.
Of the 20 patients who had diarrhoea, stool culture was available in 12. Bacillus species was grown in one patient, Candida and E. coli in a second and the remainder had no pathogens grown nor Clostridium difficile toxin detected.
There was no significant difference between the patients with and without diarrhoea, with respect to TISS (56 ± 19 vs 51 ± 18), severity of illness class (3.7 ±0.5 vs 3.7 ±0.5), antibiotic therapy, gastric colonisation, colonising organism and serum albumin concentration (27 ± 4 vs 27 ± 5 g/l respectively). The common colonising organisms were Candida albicans, Enterobacter cloacae, Klebsiella pneumoniae, Citrobacter freundii, Escherichia coli, Pseudomonas aeruginosa and yeasts other than Candida albicans.
Eight patients in the study did not receive antibiotics. Only one of these patients developed diarrhoea (13%).
Of the patients who failed to complete at least the first three days of the trial (38% of those entered), 60% failed due to high RGV, 24% got better and commenced an oral diet and the remainder died or were given the wrong feed preparation. Twenty-two patients failed to complete all six days of the study. Of these, seven died, four had high RGV, seven commenced an oral diet and four were erroneously given an enteral feed other than Isocal.
DISCUSSION
In this study, the four groups were well matched for age, diagnosis, severity of illness class, TISS and serum albumin concentration. There was no evidence to support the association between diarrhoea and enteral feeding. In the first three days of the study, there was no difference in the proportion of enterally fed patients who developed diarrhoea versus those who were not fed, being 19% in each group. The proportion of patients who developed diarrhoea with enteral feeding following a diarrhoea-free non-feed first three days was similar to the proportion of patients who developed diarrhoea without feeding following a diarrhoea-free fed first three days. This observation may be clouded by a carryover effect from the fed interval but on reviewing the patient data from those who completed six days of the trial, there appear to be few patients who had diarrhoea across the changeover period.
There was a high rate of gastric colonisation (65%) but no correlation between the development of It would appear that the basis for ICU diarrhoea is not microbiological but may well be related to intestinal villous atrophy and discoordination. 10 Voluminous and sustained diarrhoea was not a feature of this study and diarrhoea may resolve with continuing feeding. This study does not answer the question of whether nutrient absorption is altered in the presence of diarrhoea.
There was no significant difference in the serum albumin concentration in the patients with and without diarrhoea. Although a low serum albumin concentration has been associated with failure of enteral nutrition, it has never been clear whether this is a causal relationship. It may be that a low serum albumin concentration is simply a marker of severe illness with an associated greater chance of gastrointestinal failure. 7 Diarrhoea is a common complication of antibiotic therapy. In this study only eight of 62 patients did not receive antibiotics. One of these patients developed diarrhoea (13%), a smaller proportion than in the rest of the patients grouped together irrespective of feeding practice (35%). The numbers are too small to come to a definite conclusion but antibiotic therapy may promote diarrhoea in this group of patients. This has been demonstrated in thermally injured patients. 6 As all the patients in this study were critically ill and required broad spectrum antibiotics for life-threatening illnesses, the question of enteral feeding and its relationship to diarrhoea apart from the compounding effect of antibiotics is still relevant.
Failure to tolerate enteral feeding was a major feature of this study. This seems to support the intestinal malfunction as a cause of diarrhoea in the critically ill and may be a manifestation of the multi-system organ failure syndrome. 12 Enteral feeding is the preferred method of nutritional support in the critically ill patient who has a functional gastrointestinal system. It delivers nutrition via the usual route and stimulates gastrointestinal hormone production and the usual regulatory response to feeding when compared with parenteral nutrition. Enteral feeding practice is compounded by the problems of poor tolerance despite good indication for commencement of enteral feeding resulting in many days of inadequate intake. In our unit, diarrhoea used to be an indication for reduction or cessation of enteral feeding. This study demonstrates that diarrhoea is unrelated to enteral feeding, and may even resolve with continuing the feed. Several other aetiological factors are probably responsible for the diarrhoea associated with critical illness, not the least of which is antibiotic therapy. Enteral feeding should probably be continued in the presence of diarrhoea unless the diarrhoea has a microbiological cause. Further studies are required to determine if diarrhoea precludes a positive nutritional balance in the enterally fed patient.
